Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on February 22, 2007
Accepted on April 6, 2007
A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity
Timothy M. Frayling 1, Nicholas J. Timpson 2, Michael N. Weedon 1, Eleftheria Zeggini 3, Rachel M. Freathy 1, Cecilia M. Lindgren 3, John R. B. Perry 1, Katherine S. Elliott 4, Hana Lango 1, Nigel W. Rayner 3, Beverley Shields 5, Lorna W. Harries 5, Jeffrey C. Barrett 4, Sian Ellard 6, Christopher J. Groves 7, Bridget Knight 5, Ann-Marie Patch 6, Andrew R. Ness 8, Shah Ebrahim 9, Debbie A. Lawlor 10, Susan M. Ring 10, Yoav Ben-Shlomo 10, Marjo-Riitta Jarvelin 11, Ulla Sovio 11, Amanda J. Bennett 7, David Melzer 12, Luigi Ferrucci 13, Ruth J. F. Loos 14, Inês Barroso 15, Nicholas J. Wareham 14, Fredrik Karpe 7, Katharine R. Owen 7, Lon R. Cardon 4, Mark Walker 16, Graham A. Hitman 17, Colin N. A. Palmer 18, Alex S. F. Doney 19, Andrew D. Morris 19, George Davey-Smith 20, The Wellcome Trust Case Control Consortium 21, Andrew T. Hattersley 1*, Mark I. McCarthy 3
1 Genetics of Complex Traits, Institute of Biomedical and Clinical Science, Peninsula Medical School, Magdalen Road, Exeter, UK; Diabetes Genetics, Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Road, Exeter, UK. 2 Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK; The MRC Centre for Causal Analyses in Translational Epidemiology, Bristol University, Canynge Hall, Whiteladies Rd, Bristol, UK. 3 Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK. 4 Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK. 5 Diabetes Genetics, Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Road, Exeter, UK. 6 Diabetes Genetics, Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Road, Exeter, UK; The Molecular Genetics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Old Pathology Building, Barrack Road, Exeter, UK. 7 Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK. 8 Department of Oral & Dental Science, Lower Maudlin Street, Bristol, UK. 9 Department of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, UK. 10 Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, UK. 11 Department of Epidemiology and Public Health, Imperial College London, Norfolk Place, London W2 1PG, UK; Department of Public Health Science and General Practice, Fin-90014, University of Oulu, Finland. 12 Genetics of Complex Traits, Institute of Biomedical and Clinical Science, Peninsula Medical School, Magdalen Road, Exeter, UK; Epidemiology and Public Health Group, Peninsula Medical School, Barrack Road, Exeter, UK. 13 Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA. 14 MRC Epidemiology Unit, Strangeways Research Laboratories, Cambridge, UK. 15 Metabolic Disease Group, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. 16 Diabetes Research Group, School of Clinical Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne, UK. 17 Centre for Diabetes and Metabolic Medicine, Barts and The London, Royal London Hospital, Whitechapel, London, UK. 18 Population Pharmacogenetics Group, Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee, UK. 19 Diabetes Research Group, Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, UK. 20 The MRC Centre for Causal Analyses in Translational Epidemiology, Bristol University, Canynge Hall, Whiteladies Rd, Bristol, UK. 21 Membership of the Wellcome Trust Case Control Consortium is listed in the Supporting Online Material.
* To whom correspondence should be addressed.
Andrew T. Hattersley , E-mail: Andrew.Hattersley{at}pms.ac.uk
Obesity is a serious international health problem that increasesthe risk of several common diseases. The genetic factors predisposingto obesity are poorly understood. A genome-wide search for type2 diabetes susceptibility genes identified a common variantin the FTO gene that predisposes to diabetes through an effecton body mass index (BMI). An additive association of the variantwith BMI was replicated in 13 cohorts with 38,759 participants.The 16% of adults who are homozygous for the risk allele weighedabout 3 kilograms more and had a 1.67-fold increased risk ofobesity when compared with those not inheriting a risk allele.This association was observed from age 7 years upward and reflectsa specific increase in fat mass.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
NEWS OF THE WEEK
Jocelyn Kaiser (13 April 2007) Science316 (5822), 185a.
[DOI: 10.1126/science.316.5822.185a] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Obesity Gene, FTO, Is of Ancient Origin, Up-Regulated during Food Deprivation and Expressed in Neurons of Feeding-Related Nuclei of the Brain.
R. Fredriksson, M. Hagglund, P. K. Olszewski, O. Stephansson, J. A. Jacobsson, A. M. Olszewska, A. S. Levine, J. Lindblom, and H. B. Schioth (2008)
Endocrinology
149, 2062-2071
|Abstract »|Full Text »|PDF »
Recent advances in the molecular pathology, cell biology and genetics of ciliopathies.
M Adams, U M Smith, C V Logan, and C A Johnson (2008)
J. Med. Genet.
45, 257-267
|Abstract »|Full Text »|PDF »
Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI.
R. M. Freathy, N. J. Timpson, D. A. Lawlor, A. Pouta, Y. Ben-Shlomo, A. Ruokonen, S. Ebrahim, B. Shields, E. Zeggini, M. N. Weedon, et al. (2008)
Diabetes
57, 1419-1426
|Abstract »|Full Text »|PDF »
Genomics in cardiac metabolism.
J.-L. Samuel, M. C. Schaub, M. Zaugg, M. Mamas, W. B. Dunn, and B. Swynghedauw (2008)
Cardiovasc Res
|Abstract »|Full Text »|PDF »
A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function.
J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies (2008)
Endocr. Rev.
29, 133-154
|Abstract »|Full Text »|PDF »
The Association between the FTO Gene and Fat Mass in Humans Develops by the Postnatal Age of Two Weeks.
A. Lopez-Bermejo, C. J. Petry, M. Diaz, G. Sebastiani, F. de Zegher, D. B. Dunger, and L. Ibanez (2008)
J. Clin. Endocrinol. Metab.
93, 1501-1505
|Abstract »|Full Text »|PDF »
Genetic Variants of FTO Influence Adiposity, Insulin Sensitivity, Leptin Levels, and Resting Metabolic Rate in the Quebec Family Study.
R. Do, S. D. Bailey, K. Desbiens, A. Belisle, A. Montpetit, C. Bouchard, L. Perusse, M.-C. Vohl, and J. C. Engert (2008)
Diabetes
57, 1147-1150
|Abstract »|Full Text »|PDF »
Association of Morbid Obesity With FTO and INSIG2 Allelic Variants.
X. Chu, R. Erdman, M. Susek, H. Gerst, K. Derr, M. Al-Agha, G. C. Wood, C. Hartman, S. Yeager, M. A. Blosky, et al. (2008)
Arch Surg
143, 235-240
|Abstract »|Full Text »|PDF »
Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 With Susceptibility to Type 2 Diabetes in a Japanese Population.
S. Omori, Y. Tanaka, A. Takahashi, H. Hirose, A. Kashiwagi, K. Kaku, R. Kawamori, Y. Nakamura, and S. Maeda (2008)
Diabetes
57, 791-795
|Abstract »|Full Text »|PDF »
Reporting and interpretation in genome-wide association studies.
A Candidate Type 2 Diabetes Polymorphism Near the HHEX Locus Affects Acute Glucose-Stimulated Insulin Release in European Populations: Results from the EUGENE2 study.
H. Staiger, A. Stancakova, J. Zilinskaite, M. Vanttinen, T. Hansen, M. A. Marini, A. Hammarstedt, P.-A. Jansson, G. Sesti, U. Smith, et al. (2008)
Diabetes
57, 514-517
|Abstract »|Full Text »|PDF »
Required sample size and nonreplicability thresholds for heterogeneous genetic associations.
R. Moonesinghe, M. J. Khoury, T. Liu, and J. P. A. Ioannidis (2008)
PNAS
105, 617-622
|Abstract »|Full Text »|PDF »
Low Physical Activity Accentuates the Effect of the FTO rs9939609 Polymorphism on Body Fat Accumulation.
C. H. Andreasen, K. L. Stender-Petersen, M. S. Mogensen, S. S. Torekov, L. Wegner, G. Andersen, A. L. Nielsen, A. Albrechtsen, K. Borch-Johnsen, S. S. Rasmussen, et al. (2008)
Diabetes
57, 95-101
|Abstract »|Full Text »|PDF »
Variants in the Fat Mass and Obesity-Associated (FTO) Gene Are Not Associated With Obesity in a Chinese Han Population.
H. Li, Y. Wu, R. J.F. Loos, F. B. Hu, Y. Liu, J. Wang, Z. Yu, and X. Lin (2008)
Diabetes
57, 264-268
|Abstract »|Full Text »|PDF »
Origins of magic: review of genetic and epigenetic effects.
S. V Ramagopalan, M. Knight, G. C Ebers, and J. C Knight (2007)
BMJ
335, 1299-1301
|Abstract »|Full Text »|PDF »
Common Variants of the Novel Type 2 Diabetes Genes CDKAL1 and HHEX/IDE Are Associated With Decreased Pancreatic {beta}-Cell Function.
L. Pascoe, A. Tura, S. K. Patel, I. M. Ibrahim, E. Ferrannini, E. Zeggini, M. N. Weedon, A. Mari, A. T. Hattersley, M. I. McCarthy, et al. (2007)
Diabetes
56, 3101-3104
|Abstract »|Full Text »|PDF »
Evolving a definition of disease.
P. D Gluckman (2007)
Arch. Dis. Child.
92, 1053-1054
|Full Text »|PDF »
The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase.
T. Gerken, C. A. Girard, Y.-C. L. Tung, C. J. Webby, V. Saudek, K. S. Hewitson, G. S. H. Yeo, M. A. McDonough, S. Cunliffe, L. A. McNeill, et al. (2007)
Science
318, 1469-1472
|Abstract »|Full Text »|PDF »
Future Use of Genomics in Coronary Artery Disease.
Genetic Susceptibility to Peripheral Arterial Disease: A Dark Corner in Vascular Biology.
J. W. Knowles, T. L. Assimes, J. Li, T. Quertermous, and J. P. Cooke (2007)
Arterioscler. Thromb. Vasc. Biol.
27, 2068-2078
|Abstract »|Full Text »|PDF »
Assessing the social meaning, value and implications of research in genomics.
B. Lumbreras, M. Porta, and I. Hernandez-Aguado (2007)
J. Epidemiol. Community Health
61, 755-756
|Full Text »|PDF »
Tyrosine Hydroxylase: Another Piece of the Genetics of Hypertension Puzzle.
Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene.
F. Stutzmann, V. Vatin, S. Cauchi, A. Morandi, B. Jouret, O. Landt, P. Tounian, C. Levy-Marchal, R. Buzzetti, L. Pinelli, et al. (2007)
Hum. Mol. Genet.
16, 1837-1844
|Abstract »|Full Text »|PDF »
Network Medicine -- From Obesity to the "Diseasome".
A.-L. Barabasi (2007)
N. Engl. J. Med.
357, 404-407
|Full Text »|PDF »
The Genomics Gold Rush.
E. J. Topol, S. S. Murray, and K. A. Frazer (2007)
JAMA
298, 218-221
|Full Text »|PDF »
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes.
E. Zeggini, M. N. Weedon, C. M. Lindgren, T. M. Frayling, K. S. Elliott, H. Lango, N. J. Timpson, J. R. B. Perry, N. W. Rayner, R. M. Freathy, et al. (2007)
Science
316, 1336-1341
|Abstract »|Full Text »|PDF »
A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants.
L. J. Scott, K. L. Mohlke, L. L. Bonnycastle, C. J. Willer, Y. Li, W. L. Duren, M. R. Erdos, H. M. Stringham, P. S. Chines, A. U. Jackson, et al. (2007)
Science
316, 1341-1345
|Abstract »|Full Text »|PDF »